Cause of ADHD Drug Shortage; Tech Addiction In-Patient Detox; Paternal Depression

The 2022-2023 nationwide shortage of stimulant medications for attention deficit-hyperactivity disorder (ADHD) may have been driven by international supply chain disruptions rather than overprescribing, an economic evaluation suggested. (JAMA Health Forum)

One psychiatrist detailed what’s actually happening in a brain with ADHD. (The Telegraph)

In Australia, the psychedelic drug MDMA is showing promise — without serious adverse events — for post-traumatic stress disorder, though concerns remain over potential long-term side effects. (New York Times)

Even as temperatures start to rise, seasonal depression may linger for many. (New York Times)

Heavy social media usage was associated with a drop in well-being among young people, especially girls, the World Happiness Report found. (Reuters via MSN)

In back-to-back verdicts, a New Mexico jury found that Meta — Facebook and Instagram’s parent company — harmed children’s mental health and hid its knowledge of child exploitation on its social media platforms, while a California jury found Meta and YouTube liable for harms to children using their services. (AP)

A Seattle clinic is treating tech addiction like a drug addition — with up to a 16-week in-patient detox. (Fortune via AOL)

People with schizophrenia or depression had reduced grip strength compared with healthy controls, a study found. (JAMA Psychiatry)

Mental health symptoms, such as suicidal ideation and restlessness, are on the rise among U.S. college students. (The Hill)

Fathers had lower rates of incident psychiatric disorders during pregnancy and the early postpartum period, which thereafter rebounded to preconception levels, Swedish data showed. However, incidence rate ratios for depression and stress-related disorders at 1 year postpartum were roughly 30% higher compared with preconception levels. (JAMA Network Open)